No Data
Cutia Therapeutics' Phase 2 Trial of Drug for Adipose Accumulation-Related Diseases Complete Database Lock
Cutia Therapeutics Records 130% Higher Revenue From Commercialized Products in Nine Months to September
HK stocks unusual movement, Kedi rose nearly 10%, the first three quarters of product revenue increased by about 1.3 times.
Gelonghui October 31st | KeDi-B (2487.HK) rose in the afternoon, rising nearly 10% at one point to HK$14.1. On the news front, the group announced that as of the end of September, the revenue from commercialized products was approximately 0.149 billion yuan, an increase of about 1.3 times year-on-year. (Gelonghui)
Kedi-B's revenue from commercialized products in the first three quarters is about 0.1489 billion yuan, a year-on-year increase of about 129.9%.
Kede-B (02487) announced that as of the nine months ended September 30, 2024, the group's commercialized product revenue was approximately RMB 0.1489 billion, achieving a positive growth of about 129.9% compared to the same period in 2023.
Kede Bi-B (02487.HK): The revenue from commercialized products in the first three quarters increased by 129.9% year-on-year.
KeDi-B (02487.HK) announced on October 31 that as of the nine months ending September 30, 2024, the group's commercialized product revenue was approximately RMB 0.1489 billion, recording a positive growth of about 129.9% compared to the same period in 2023.
Repurchase gatherings on October 30: Aia, Swire Pacific A, and others have repurchased one after another, with Aia spending 62.6635 million Hong Kong dollars.
According to hkex's disclosure on October 31, Aia, Swire Pacific A, and other companies repurchased shares.① Aia repurchased 1.0168 million shares of common stock on October 30, involving 62.6635 million Hong Kong dollars, with a repurchase price per share ranging from 62.6 Hong Kong dollars to 61.15 Hong Kong dollars. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.319 billion shares, accounting for 2.837% of the number of issued shares when the ordinary resolution was passed.② Swire Pacific A
No Data
No Data